Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116044) titled 'Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection' on Aug. 4.
Study Type: Observational [Patient Registry]
Primary Sponsor: University of Molise
Condition:
Evaluate Response to Treatment Both Biochemically and Virologically to Determine the Safety and Effectiveness of Bulevirtide Therapy in HDV Patients
Intervention:
Diagnostic Test: virological tests diagnostic tests
Recruitment Status: Not recruiting
Date of First Enrollment: June 15, 2023
Target Sample Size: 160
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/ct2/sho...